144 Smoking cessation advice and help for lung cancer patients – an audit of current practicedoi:10.1016/S0169-5002(13)70144-2Eng, L.Lee, L.Elsevier Ireland LtdLung Cancer
O. et al. Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients. Proc. Natl Acad. Sci. USA 114, 4993–4998 (2017). Article CAS PubMed PubMed Central Google Scholar Im, S. J. et al. Defining CD8+ T cells that provide the ...
In 2024, increased patient centricity—driven by patient empowerment, accelerated personalized therapies, and regulatory mandates—will become a focus for life sciences organizations, challenging the status quo. From a pharma perspective, this is about focusing as much on the patient journey and overall...
Being a smoker was associated with reduced likelihood of help-seeking (OR 0.44; 95% CI 0.23 to 0.83), even after adjusting for demographic factors (OR 0.46; 95% CI 0.21 to 1.00). Delay in help-seeking in smokers for a symptom that is potentially indicative of lung cancer is a cause ...
We understand cancer treatment is a personal journey. Utah Cancer Specialists are united in a singular focus: help patients find a path to hope and healing.
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study;Brit J. Nutr; 2012 Jul;108(2):327-33. Concetta Finocchiaro et al -https://pubmed.ncbi.nlm.nih.gov/22114792/ Should omega-3 fatty acids be used for adjuvant treatment of cancer ...
“This may help us identify patients that might respond to this therapy, as well as help us understand how to potentially combine other immunotherapies to improve response rates,” he added. “We are grateful to the extremely dedicated clients who sought any and all possible care for their pets...
the effects of stage migration in the traditional 3-stage TNM (tumor, node, metastasis) system with those in a new expanded 5-stage system, which has two additional stages for the poor prognostic groups, we used both systems to classify a cohort of 178 patients with primary lung cancer. To...
Nurses should educate patients not only about screening guidelines, but about important cancer risks to help improve cancer prevention. Debi Fischer, MSW, BSN, BA, LCSW, RN In 2023, the theme for National Cancer Prevention Month, which takes place in February, is “Close the Care Gap.” ...
the cancer community has learned a great deal about precision medicine, particularly for non-small cell lung cancer, but if patients aren't getting comprehensive biomarker testing, then they are less likely to benefit from all of the therapeutic advancements. We welcome programs like Amgen's Biomar...